Clinical Outcomes for Heart‐Alone and Multiorgan Transplant Under the New Heart Allocation Policy Era
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.036687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Keshvi Chauhan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine University of Wisconsin-Madison Madison WI United States. Hauptthemen laut MEDLINE: Heart Transplantation, Waiting Lists, Tissue and Organ Procurement, Health Policy. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
In October 2018, a new heart transplant allocation policy was implemented in the United States to address inequalities. Under the new policy, some patient outcomes for patients with heart transplant have improved; however, outcomes of multiorgan transplants combined with heart remain unclear.
Methods
We examined the waitlist mortality, time to transplant, and posttransplant survival for all patients listed between 2013 and 2022 for multiorgan transplants with heart (n=3798) and compared the old policy era to the new policy era using cumulative incident curves and multivariable Cox regression models. Cumulative incidence curves also compared multiorgan transplants to patients listed for heart alone (n=31 840) under the new policy era.
Results
Patients awaiting multiorgan transplants had higher use of intra‐aortic balloon pumps (4.7% versus 11%) and extracorporeal membrane oxygenation support (2.4% versus 4.9%) in the new policy era. Under the new policy, despite receiving transplants sooner (n=2200 transplants, hazard ratio [HR], 1.74 [95% CI, 1.59–1.91]), patients who received multiorgan transplants had no change in waitlist mortality (n=340 deaths, HR, 1.06 [95% CI, 0.84–1.34]) compared with the old policy era. The rate of death post‐multiorgan transplant was significantly higher in incidence curves under the new policy compared with the old policy era (log‐rank P =0.02). However, in multivariable Cox models, the risk of death post‐multiorgan transplant was similar under the new policy (n=287 deaths, HR, 1.11 [95% CI, 0.87–1.41]) compared with the old policy era.
Conclusions
Under the new policy, waitlist deaths have decreased for patients awaiting heart alone, but not for those awaiting multiorgan transplants. Post‐transplant survival remains lower for patients who underwent multiorgan transplant (compared with heart‐alone transplant), with no change under the new policy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine University of Wisconsin-Madison Madison WI United States.
- Cardiovascular Division University of Wisconsin-Madison Madison WI United States.
- Transplant Medicine University of Wisconsin-Madison Madison WI United States.
- Cardiothoracic Surgery Froedtert Hospital Milwaukee WI United States.
- Cardiovascular Division, Medical College of Wisconsin Froedtert Hospital Milwaukee WI United States.
ORCID-Profile: Didier Mandelbrot, Takushi Kohmoto, Ravi Dhingra
Zitieren
APA
Chauhan, K., Hess, T., Mandelbrot, D., Kohmoto, T., & Dhingra, R. (2025). Clinical Outcomes for Heart‐Alone and Multiorgan Transplant Under the New Heart Allocation Policy Era. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036687
Vancouver
Chauhan K, Hess T, Mandelbrot D, Kohmoto T, Dhingra R. Clinical Outcomes for Heart‐Alone and Multiorgan Transplant Under the New Heart Allocation Policy Era. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.036687
BibTeX
@article{Chauhan2025,
author = {Chauhan, Keshvi and Hess, Timothy and Mandelbrot, Didier and Kohmoto, Takushi and Dhingra, Ravi},
title = {Clinical Outcomes for Heart‐Alone and Multiorgan Transplant Under the New Heart Allocation Policy Era},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.036687}
}
EUVIMED